These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 14567250)
1. [Recent findings based on the results of the post-marketing surveillance of vancomycin hydrochloride for intravenous infusion]. Shimada K Jpn J Antibiot; 2003 Aug; 56(4):259-71. PubMed ID: 14567250 [TBL] [Abstract][Full Text] [Related]
2. [Clinical studies on vancomycin in the treatment of MRSA infection]. Shimizu K; Orizu M; Kanno H; Kitamura S; Konishi T; Soma K; Nishitani H; Noguchi Y; Hasegawa S; Hasegawa H; Wada K Jpn J Antibiot; 1996 Aug; 49(8):782-99. PubMed ID: 9053533 [TBL] [Abstract][Full Text] [Related]
3. [Effect of inhaled vancomycin hydrochloride on elimination of methicillin-resistant Staphylococcus aureus]. Shirai M; Ide K; Sato M; Murakami M; Tanaka Y; Sato A; Chida K Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Nov; 33(11):1233-9. PubMed ID: 8583715 [TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy of therapeutic drug monitoring in patients receiving vancomycin. Iwamoto T; Kagawa Y; Kojima M Biol Pharm Bull; 2003 Jun; 26(6):876-9. PubMed ID: 12808304 [TBL] [Abstract][Full Text] [Related]
6. [Intravenous vancomycin treatment in children; its clinical usefulness and serum concentration monitoring]. Fujita K; Murono K; Yoshikawa M; Miyamoto K Jpn J Antibiot; 1993 Jul; 46(7):505-10. PubMed ID: 8371487 [TBL] [Abstract][Full Text] [Related]
7. Effect of vancomycin therapy for osteomyelitis on colonization by methicillin-resistant Staphylococcus aureus: lack of emergence of glycopeptide resistance. Bernard L; Vaudaux P; Vuagnat A; Stern R; Rohner P; Pittet D; Schrenzel J; Hoffmeyer P; Infect Control Hosp Epidemiol; 2003 Sep; 24(9):650-4. PubMed ID: 14510246 [TBL] [Abstract][Full Text] [Related]
8. The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid. Stein GE; Wells EM Curr Med Res Opin; 2010 Mar; 26(3):571-88. PubMed ID: 20055750 [TBL] [Abstract][Full Text] [Related]
9. Monitoring of vancomycin serum levels for the treatment of staphylococcal infections. Kitzis MD; Goldstein FW Clin Microbiol Infect; 2006 Jan; 12(1):92-5. PubMed ID: 16460555 [TBL] [Abstract][Full Text] [Related]
11. [Combination effect between panipenem and vancomycin on highly methicillin-resistant Staphylococcus aureus]. Fukuoka T; Domon H; Kakuta M; Ishii C; Hirasawa A; Utsui Y; Ohya S; Yasuda H Jpn J Antibiot; 1997 Apr; 50(4):411-9. PubMed ID: 9192249 [TBL] [Abstract][Full Text] [Related]
12. Review of continuous-infusion vancomycin. DiMondi VP; Rafferty K Ann Pharmacother; 2013 Feb; 47(2):219-27. PubMed ID: 23386074 [TBL] [Abstract][Full Text] [Related]
13. Oral step-down therapy is comparable to intravenous therapy for Staphylococcus aureus osteomyelitis. Daver NG; Shelburne SA; Atmar RL; Giordano TP; Stager CE; Reitman CA; White AC J Infect; 2007 Jun; 54(6):539-44. PubMed ID: 17198732 [TBL] [Abstract][Full Text] [Related]
14. Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. Stevens DL; Herr D; Lampiris H; Hunt JL; Batts DH; Hafkin B Clin Infect Dis; 2002 Jun; 34(11):1481-90. PubMed ID: 12015695 [TBL] [Abstract][Full Text] [Related]
15. Pediatric pharmaceutical care with anti-infective medication in a patient with acute hematogenous osteomyelitis caused by methicillin-resistant Lv C; Lv J; Liu Y; Liu Q; Zou D Int J Immunopathol Pharmacol; 2020; 34():2058738420925713. PubMed ID: 32567423 [TBL] [Abstract][Full Text] [Related]
16. [Demethyl-vancomycin in treatment of resistant staphylococcal infections. A clinical evaluation]. Zhu F Zhonghua Yi Xue Za Zhi; 1992 Sep; 72(9):562-4, 575. PubMed ID: 1338524 [TBL] [Abstract][Full Text] [Related]
17. Sustained-release vancomycin sheet may help to prevent prosthetic graft methicillin-resistant Staphylococcus aureus infection. Hirose K; Marui A; Arai Y; Nomura T; Inoue S; Kaneda K; Kamitani T; Fujita M; Mitsuyama M; Tabata Y; Komeda M J Vasc Surg; 2006 Aug; 44(2):377-82. PubMed ID: 16890872 [TBL] [Abstract][Full Text] [Related]
18. Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan. Kohno S; Yamaguchi K; Aikawa N; Sumiyama Y; Odagiri S; Aoki N; Niki Y; Watanabe S; Furue M; Ito T; Croos-Dabrera R; Tack KJ J Antimicrob Chemother; 2007 Dec; 60(6):1361-9. PubMed ID: 17913720 [TBL] [Abstract][Full Text] [Related]
19. Linezolid reduces length of stay and duration of intravenous treatment compared with vancomycin for complicated skin and soft tissue infections due to suspected or proven methicillin-resistant Staphylococcus aureus (MRSA). Itani KM; Weigelt J; Li JZ; Duttagupta S Int J Antimicrob Agents; 2005 Dec; 26(6):442-8. PubMed ID: 16289514 [TBL] [Abstract][Full Text] [Related]
20. Treatment of infective endocarditis caused by methicillin-resistant Staphylococcus aureus: teicoplanin versus vancomycin in a retrospective study. Huang JH; Hsu RB Scand J Infect Dis; 2008; 40(6-7):462-7. PubMed ID: 18584532 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]